HYDROCHLOROTHIAZIDE
- Product NDC
- 70518-2540
- 11-digit product format
- 705182540
- Labeler code
- 70518
- Product ID
- 70518-2540_dc25cf2f-05c0-036b-e053-2a95a90a396a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- HYDROCHLOROTHIAZIDE
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- ANDA040702
- Marketing category
- ANDA
- Marketing start
- 2020-01-13
- Marketing end
- 0000-00-00
- Substance
- HYDROCHLOROTHIAZIDE
- Active strength
- 13 mg/1
- Pharmacologic classes
- Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 70518-2540 | D | Discontinued by firm | 2026-08-17 | ||
| excluded package | package | 70518-2540 | 70518-2540-0 | D | Discontinued by firm | 2026-08-17 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 70518-2540-0 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 70518-2540-0 | I | Inactivated by FDA | 1332a3947898… | d4bfe170f9cd… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A040702-001 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | |
| A040702-002 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | |
| A040702-003 | HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A040702-001 | AB |
| A040702-002 | AB |
| A040702-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-002 | HYDROCHLOROTHIAZIDE | 50MG | TABLET / ORAL | AB | 2007-03-16 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-003 | HYDROCHLOROTHIAZIDE | 12.5MG | TABLET / ORAL | AB | 2017-05-10 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040702-001 | HYDROCHLOROTHIAZIDE | 25MG | TABLET / ORAL | AB | 2007-03-16 | 1e350fbaab3a… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A040702-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040702-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A040702-003 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A040702-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A040702-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A040702-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A040702-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A040702-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A040702-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A040702-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A040702-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A040702-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A040702-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A040702-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A040702-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A040702-001 | AB | 1 | 1e350fbaab3a… |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 70518-2540-0 | 2025-09-11 | C162847 | 48780-1 | 1030e365-11fd-111a-e063-dadaa90a10e2 | HYDROCHLOROTHIAZIDE TABLETS, USP Rx only |
| 70518-2540-0 | 2024-01-30 | C162847 | 48780-1 | 1030e365-11fd-111a-e063-dadaa90a10e2 | HYDROCHLOROTHIAZIDE TABLETS, USP Rx only |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 70518-2540 | HYDROCHLOROTHIAZIDE TABLET [REMEDYREPACK INC.] | 5 | Legacy NDC | 20220409_f30a7b7c-1271-4243-8203-b9d6ab3abf09.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 03b7e52e-0003-47c3-af12-93ef00800b37 | 2026-07-16 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Golden State Medical Supply, Inc. | a85f69f5-ba97-478d-e053-2a95a90a0a97 | 2026-07-06 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Leading Pharma, LLC | 8c868894-667e-4a51-906a-838d63e420ba | 2026-06-12 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | St. Mary's Medical Park Pharmacy | 099496f1-4e2d-8d21-e063-6294a90af695 | 2026-06-03 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Northwind Health Company, LLC | f331769a-ff11-6c68-e053-2a95a90a493b | 2026-01-01 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f9faec8a-2b71-47bb-a296-48ecbce9af50 | 2025-12-16 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | REMEDYREPACK INC. | 71691ccf-0ed9-4a14-8da6-7ab9b9698f52 | 2025-10-16 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Preferred Pharmaceuticals Inc. | 93f6a018-8b3d-4f40-be25-902daec19aea | 2025-01-21 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NCS HealthCare of KY, LLC dba Vangard Labs | 4c1a92c0-b491-4ae9-8bd0-029beb2b13c6 | 2024-08-12 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1e02787f-ccb5-abc2-e063-6294a90af7c3 | 2024-07-24 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | NuCare Pharmaceuticals,Inc. | 1884db5f-72b5-6b0c-e063-6394a90a0e49 | 2024-05-15 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | A-S Medication Solutions | 2dd7c2a4-d335-4c6f-b1e6-b0ae6eebab84 | 2023-02-15 | Warnings, Adverse reactions | 040702 ANDA040702 |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Proficient Rx LP | 6be05675-c4b4-4e1e-9047-044a7fc7cef6 | 2021-01-01 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | e8ca7334-4b58-4f4b-bf36-0ab47b60ff7c | 2020-12-14 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | ec70ea28-a219-45d1-9d5b-6a79c7ef4987 | 2020-10-28 | Warnings, Adverse reactions | 040702 ANDA040702 |
| HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDE | Aphena Pharma Solutions - Tennessee, LLC | 2febae4f-836e-4935-bd06-3495f87b3b82 | 2017-08-15 | Warnings, Adverse reactions | 040702 ANDA040702 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 70518-2540-0 | 70518254000 | 30 TABLET in 1 BLISTER PACK (70518-2540-0) | 30 tablet | 2020-01-13 | 0000-00-00 | No | No | Current |